Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20160103025821N5Phase 3Completed
Phase 3 trial of oxytocin in Fibromyoma (LM), sponsored by Tabriz University of Medical Sciences. Primary endpoint: Absorbed irrigation fluid volume. Started Feb 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20160103025821N5.